SCHEMBL188287

SCHEMBL188287

Cc1cc(N)ccc1N1CCN(C2CC2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
ALDH1A1 P00352 6/20 0.63
GAA P10253 4/20 0.63
MEN1 O00255 2/20 0.63
THRB P10828 2/20 0.63
KMT2A Q03164 2/20 0.63
NR4A1 P22736 1/20 0.63
PTK2B Q14289 1/20 0.63
RAD52 P43351 2/20 0.59
GFER P55789 2/20 0.59
HTT P42858 1/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
ALOX15 P16050 1/20 0.46
FLT3 P36888 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.40
ALOX12 P18054 1/20 0.40
POLB P06746 1/20 0.40
SLC18A3 Q16572 2/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1812259 0.94 ALDH1A1 (0.64) MAPTALDH1A1GAAMEN1THRB
SCHEMBL328198 0.91 ALDH1A1 (0.56) MAPTALDH1A1GAAMEN1THRB
SCHEMBL10035939 0.88 MAPT (0.56) MAPTALDH1A1GAAMEN1THRB
SCHEMBL10126824 0.88 ALDH1A1 (0.69) MAPTALDH1A1GAAMEN1THRB
SCHEMBL17631310 0.86 ALDH1A1 (0.58) MAPTALDH1A1GAAMEN1THRB
SCHEMBL15358737 0.86 MAPT (0.81) MAPTALDH1A1GAAMEN1THRB
SCHEMBL10036371 0.84 MAPT (0.55) MAPTALDH1A1GAAMEN1THRB
SCHEMBL6052282 0.84 MAPT (0.55) MAPTALDH1A1GAAMEN1THRB
SCHEMBL15709814 0.82 ALDH1A1 (0.52) MAPTALDH1A1GAAMEN1THRB
SCHEMBL15709816 0.82 MAPT (0.52) MAPTALDH1A1GAAMEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2017278-B1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE MSD KK (JP) 2016-11-02 EP disclosed
US-20140303178-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVES MSD KK (JP) 2014-10-09 US disclosed
US-8791125-B2 Dihydropyrazolopyrimidinone derivatives MSD K.K. (JP) 2014-07-29 US disclosed
US-8288396-B2 Pyrimidopyrimidoindazole derivative MSDKK (JP) 2012-10-16 US disclosed
CN-101432284-B Dihydropyrazolopyrimidinone derivative MSD KK 2012-08-15 CN disclosed
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-05-31 US disclosed
EP-2401281-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-01-04 EP disclosed
US-20110189130-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVES SAGARA TAKESHI 2011-08-04 US disclosed
US-7935708-B2 Dihydropyrazolopyrimidinone derivatives MSD K.K. (JP) 2011-05-03 US disclosed
US-7834019-B2 Substituted pyrazolo[3,4-d]pyrimidinone derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-11-16 US disclosed
WO-2010098367-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-09-02 WO disclosed
US-20100063024-A1 Dihydropyrazolopyrimidinone Derivatives MERCK SHARP & DOHME LLC 2010-03-11 US disclosed
CN-101432284-A Dihydropyrazolopyrimidinone derivative BANYU PHARMA CO LTD (JP) 2009-05-13 CN disclosed
EP-2017278-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-01-21 EP disclosed
US-20070254892-A1 Dihydropyrazolopyrimidinone derivatives MSD K.K. (JP) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110189130-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVES WEE1, WEE2, GRK3 MAPT 4041/4885ALDH1A1 755/4885GAA 3719/4885
US-20100063024-A1 Dihydropyrazolopyrimidinone Derivatives WEE1, WEE2, GRK3 MAPT 4041/4885ALDH1A1 755/4885GAA 3719/4885
US-20070254892-A1 Dihydropyrazolopyrimidinone derivatives WEE1, WEE2, GRK3 MAPT 4041/4885ALDH1A1 755/4885GAA 3719/4885
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE WEE1, WEE2, DCK MAPT 4723/4885ALDH1A1 1119/4885GAA 3616/4885
US-20140303178-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVES WEE1, WEE2, GRK3 MAPT 4041/4885ALDH1A1 755/4885GAA 3719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.